Summary: Gestalt and Paige have partnered to integrate Paige’s advanced AI applications into Gestalt’s PathFlow, streamlining pathology workflows and enhancing diagnostic accuracy for improved patient care.

Takeaways:

  1. The partnership enables seamless integration of Paige’s AI algorithms within Gestalt’s PathFlow, enhancing diagnostic confidence and supporting pathologists in delivering precise results.
  2. By consolidating AI-powered diagnostic tools into a single platform, PathFlow users can experience more streamlined workflows, reducing diagnostic time and improving efficiency.
  3. PathFlow’s expanded capabilities, accessible to all Gestalt users, allow for comprehensive support across various pathology use cases, benefiting both current and future customers in cancer detection and beyond.

Gestalt, a digital pathology solutions provider, and Paige, a developer of next-generation AI technology for pathology, announced a strategic partnership to integrate Paige’s advanced AI applications within Gestalt’s PathFlow solution. 

A Collaboration to Improve Pathology

This collaboration aims to streamline the delivery of integrated workflows, optimizing the pathologist’s experience while ensuring patient accuracy and safety by working in a single environment.

Gestalt’s PathFlow is widely recognized for its robust capabilities in primary diagnosis, education, resident training, and research workflows. By incorporating Paige’s cutting-edge algorithms, the PathFlow solution will now offer an even broader range of tools to support pathologists in delivering precise and efficient diagnoses.

All of Paige’s AI applications will be made available in PathFlow, enabling both current and new users to seamlessly access AI-powered diagnostic capabilities. This integration supports more efficient case reviews, accelerates diagnostic timelines, and promotes a comprehensive approach to cancer detection.

“By partnering with Paige to include their AI applications in PathFlow, we are reinforcing our commitment to providing pathologists with the best tools available,” says Lisa-Jean Clifford, COO & Chief Strategy Officer of Gestalt. “This partnership underscores our dedication to enhancing the pathologist’s experience and ensuring the highest standards of patient care.”

Further reading: Independent Pathology Service Adopts PathAI’s Digital Image Management System

Highlights of the Partnership:

  • Enhanced Diagnostic Confidence: The integration of Paige’s AI applications will provide pathologists with powerful tools to improve diagnostic confidence and patient outcomes.
  • Streamlined Workflows: The combined technologies will ensure seamless workflows, reducing the time and effort required for pathologists to reach diagnoses.
  • Comprehensive Support: PathFlow’s expanded algorithm library will cater to a wide range of use cases, benefiting both current and future customers.
  • Paige’s availability through PathFlow’s platform will allow easy access to Paige AI solutions for any Gestalt user.

“Leveraging Paige’s AI-powered applications, PathFlow users can experience an enhanced workflow that supports efficient case review, accelerates time to diagnosis, and allows for a more comprehensive approach to cancer detection, enabling pathologists to focus on what matters most—delivering precise and actionable insights for patient care,” says Peter Hamilton, general manager for diagnostics at Paige.